Real-time enrollment status for this severe combined immunodeficiency clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 3:46 PM UTC
| NCT Number | NCT00055172 |
| Recruiting Status | Recruiting |
| Condition | Severe Combined Immunodeficiency |
| Phase | Clinical Trial |
| Target Enrollment | 100 participants |
| Active Locations | 1 sites in the US |
| Sponsor | National Heart, Lung, and Blood Institute (NHLBI) |
| Last Updated on CT.gov | July 10, 2026 (3 days ago) |
As of July 13, 2026: Clinical trial NCT00055172 is currently recruiting participants. This clinical trial study for severe combined immunodeficiency is actively seeking new participants at 1 location across the United States. The study is sponsored by National Heart, Lung, and Blood Institute (NHLBI). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT00055172 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT00055172 was last updated 3 days ago (July 10, 2026). HelloStudys verifies this status automatically.